US Patent
US7947017 — Devices, systems and methods for medicament delivery
Formulation · Assigned to Intelliject Inc · Expires 2028-03-12 · 2y remaining
Vulnerability score
60/100
Moderate — design-around opportunities exist
What this patent protects
This patent protects an apparatus for a medical device with a movable member, valve, and needle for delivering a medicament.
USPTO Abstract
An apparatus includes a movable member and a valve coupled to the movable member. The movable member is configured to be disposed within a housing of a medical device and has a first end portion and second end portion. A portion of the first end portion is configured to define a portion of a boundary of a gas chamber. The first end portion defines an opening configured to be in fluid communication between the gas chamber and an area outside the gas chamber. The second end portion is configured to be coupled to a needle configured to deliver a medicament into a body. The valve is configured to selectively allow fluid communication between the gas chamber and the area outside the gas chamber through the opening defined by the first end portion of the movable member.
Drugs covered by this patent
- Epipen (epinephrine) · Pfizer Inc.
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.